The role of folate in depression and dementia

Journal of Clinical Psychiatry

Volumn 68, Issue SUPPL. 10, 2007, Pages 28-33

  Mischoulon, David ^a   Raab, Michael Franz ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Lee Memorial Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; CEREFOLIN; DEPLIN; DESIPRAMINE; FLUOXETINE; FOLIC ACID; LITHIUM CARBONATE; METHYLFOLATE; UNCLASSIFIED DRUG;

BRAIN; COGNITION; COMBINATION CHEMOTHERAPY; CORRELATION ANALYSIS; DEMENTIA; DEPRESSION; DIET SUPPLEMENTATION; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; FOOD AND DRUG ADMINISTRATION; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

AGED; BRAIN; DEMENTIA; DEPRESSIVE DISORDER, MAJOR; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS;

EID: 34848887427     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Wu D, Partridge WM. Blood-brain barrier transport of reduced folic acid. Pharm Res 1999;16:415-419
2. Spector R, Lorenzo AV. Folate transport in the central nervous system. Am J Physiol 1975;229:777-782
3. 12 and folate deficiency. Arch Intern Med 1999;159:1289-1298
4. Goff DC, Bottiglieri T, Arning E, et al. Folate, homocysteine, and negative symptoms in schizophrenia. Am J Psychiatry 2004;161:1705-1708
5. Herbert V. Experimental nutritional folate deficiency in man. Trans Assoc Am Physicians 1962;75:307-320
6. Bottiglieri T, Hyland K, Laundy M, et al. Folate deficiency, biopterin and monoamine metabolism in depression. Psychol Med 1992;22:871-876
7. Reynolds EH, Preece JM, Bailey J, et al. Folate deficiency in depressive illness. Br J Psychiatry 1970;117:287-292
8. Bottiglieri T, Laundy M, Crellin R, et al. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000;69:228-232
9. Ghadirian AM, Ananth J, Engelsmann F. Folic acid deficiency and depression. Psychosomatics 1980;21:926-929
10. Carney MWP, Chary TKN, Laundy M, et al. Red cell folate concentrations in psychiatric patients. J Affect Disord 1990;19:207-213
11. Shorvon SD, Carney MWP, Chanarin I, et al. The neuropsychiatry of megaloblastic anaemia. Br Med J 1980;281:1036-1038
12. Wilkinson AM, Anderson DN, Abou-Saleh MT, et al. 5-Methyltetrahydrofolate level in the serum of depressed subjects and its relationship to the outcome of ECT. J Affect Disord 1994;32:163-168
13. Carney MWP. Serum folate values in 423 psychiatric patients. Br Med J 1967;4:512-516
14. 12, and homocysteine in major depressive disorder. Am J Psychiatry 1997;154:426-428
15. Tolmunen T, Voutilainen S, Hintikka J, et al. Dietary folate and depressive symptoms are associated in middle-aged Finnish men. J Nutr 2003;133:3233-3236
16. Morris MS, Fava M, Jacques PF, et al. Depression and folate status in the US population. Psychother Psychosom 2003;72:80-87
17. Kaufman S. Some metabolic relationships between biopterin and folate: implications for the "methyl trap hypothesis." Neurochem Res 1991;16:1031-1036
18. Hamon CB, Blair JA, Barford PA. The effect of tetrahydrofolate on tetrahydrobiopterin metabolism. J Ment Defic Res 1986;30:179-183
19. Mann SP, Hill MW. Activation and inactivation of striatal tyrosine hydroxylase: the effects of pH, ATP and cyclic AMP, S-adenosylmethionine and S-adenosylhomocysteine. Biochem Pharmacol 1983;32:3369-3374
20. Sontag E, Nunbhakdi-Craig V, Sontag JM, et al. Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J Neurosci 2007;27:2751-2759
21. Blusztajn JK, Liscovitch M, Richardson UI. Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line. Proc Natl Acad Sci U S A 1987;84:5474-5477
22. Blusztajn JK, Liscovitch M, Mauron C, et al. Phosphatidylcholine as a precursor of choline for acetylcholine synthesis. J Neural Transm Suppl 1987;24:247-259
23. Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr 2006;26:229-250
24. Muccioli G, Scordamaglia A, Bertacco S, et al. Effect of S-adenosyl-L-methionine on brain muscarinic receptors of aged rats. Eur J Pharmacol 1992;227:293-299
25. Kuncl RW, Drachman DB, Adams R. Inhibition of methyltransferase reduces the turnover of acetylcholine receptors. Proc Natl Acad Sci U S A 1988;85:4032-4036
26. Hirata F, Axelrod J. Phospholipid methylation and biological signal transmission. Science 1980;209:1082-1090
27. Ruck A, Kramer S, Metz J, et al. Methyltetrahydrofolate is a potent and selective agonist for kainic acid receptors. Nature 1980;287:852-853
28. Wang JK, Andrews H, Thukral V. Presynaptic glutamate receptors regulate noradrenaline release from isolated nerve terminals. J Neurochem 1992;58:204-211
29. Alpert JE, Mischoulon D. One-carbon metabolism and the treatment of depression: roles of S-adenosyl methionine (SAMe) and folic acid. In: Mischoulon D, Rosenbaum J, eds. Natural Medications for Psychiatric Disorders: Considering the Alternatives. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:43-67
30. 12 with depression in a middle-aged community sample. Psychol Med 2005;35:529-538
31. 12, homocysteine, and the MTHFR 677C→T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 2003;60:618-626
32. 12, deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am J Psychiatry 2000;157:715-721
33. 12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 2002; 159:2099-2101
34. Arinami T, Yamada N, Yamakawa-Kobayashi K, et al. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 1997;74:526-528
35. Hickie I, Scott E, Naismith S, et al. Late-onset depression: genetic, vascular and clinical contributions. Psychol Med 2001;31:1403-1412
36. Kelly CB, McDonnell AP, Johnston TG, et al. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. J Psychopharmacol 2004;18:567-571
37. Kunugi H, Fukuda R, Hattori M, et al. C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry 1998;3:435-437
38. Tan EC, Chong SA, Lim LC, et al. Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet 2004;14:227-231
39. Reif A, Pfuhlmann B, Lesch KP. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1162-1168
40. Zintzaras E. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet 2006;16:105-115
41. Papakostas GI, Iosifescu DV, Renshaw PF, et al. Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder, part 2. Psychiatry Res 2005;140:301-307
42. 12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry 2004;65:1090-1095
43. 12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int J Neuropsychopharmacol 2005;8:523-528
44. 12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy. J Clin Psychiatry 2004;65:1096-1098
45. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo controlled trial. J Affect Disord 2000;60:121-130
46. Alpert JE, Mischoulon D, Rubenstein GE, et al. Folinic acid (leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry 2002;14:33-38
47. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr 2002;76:1158s-1161s
48. Young SN. Clinical nutrition: 3. The fuzzy boundary between nutrition and psychopharmacology. Can Med Assoc J 2002;166:205-209
49. Surtees R, Heales S, Bowron A. Association of cerebrospinal fluid deficiency of 5-methyltetrahydrofolate, but not S-adenosylmethionine, with reduced concentrations of the acid metabolites of 5-hydroxytryptamine and dopamine. Clin Sci 1994; 86:697-702
50. Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004;50:3-32
51. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Alzheimer's Disease and Other Dementias of Late Life. Available at http://www.psych.org/psych_pract/treatg/pg/AlzheimersPG_05-15-06.pdf. Accessed Aug 28, 2006
52. Malberg JE. Implications of adult hippocampal neurogenesis in antidepressant action. J Psychiatry Neurosci 2004;29:196-205
53. Pereira AC, Huddleston DE, Brickman AM, et al. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci USA 2007;204:5638-5643
54. Kronenberg G, Bick-Sander A, Bunk E, et al. Physical exercise prevents age-related decline in precursor cell activity in the mouse dentate gyrus. Neurobiol Aging 2006;27:1505-1513
55. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimers disease. Arch Neurol 2005;62:1556-1560
56. Solomon A, Kareholt I, Ngandu T, et al. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology 2007;68:751-756
57. Skoog I. Hypertension and cognition. Int Psychogeriatr 2003;15(suppl 1):139-146
58. Corrada MM, Kawas CH, Hallfrisch J, et al. Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging. Alzheimers Dement 2005;1:11-18
59. Fioravanti M, Ferrario E, Massaia M, et al. Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr 1997;26:1-13
60. Nilsson K, Gustafson L, Hulgberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001;16:609-614
61. 12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 2005;118:161-167
62. Ramos MI, Allen LH, Mungas DM, et al. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2005;82:1346-1352
63. 6-folate treatment improves blood-brain barrier function in patients with hyperhomocystein-aemia and mild cognitive impairment. Dement Geriatr Cogn Disord 2003;16:145-150
64. Bryan J, Calvaresi E, Hughes D. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. J Nutr 2002;132:1345-1356
65. Garcia AA, Haron Y, Evans LR, et al. Metabolic markers of cobalamin deficiency and cognitive function in normal older adults. J Am Geriatr Soc 2004;52:66-71
66. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-1455
67. McCaddon A, Hudson P, Davies G, et al. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001;12:309-313
68. Wright CB, Lee HS, Paik MC, et al. Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study. Neurology 2004;63:254-260
69. Teunissen CE, Blon AH, Van Boxtel MP, et al. Homocysteine: a marker for cognitive performance? a longitudinal follow-up study. J Nutr Health Aging 2003;7:153-159
70. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483
71. Kruman II, Mouton PR, Emokpae R Jr, et al. Folate deficiency inhibits proliferation of adult hippocampal progenitors. Neuroreport 2005;16:1055-1059
72. Kruman II, Culmsee C, Chan SL, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000;20:6920-6926
73. Lipton SA, Won-Ki K, Yun-Beom C, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 1997;94:5923-5928
74. Ho PI, Collins SC, Dhitavat S, et al. Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. J Neurochem 2001;78:249-253
75. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998;316:894-898
76. Smith I, Hyland K, Kendall B. Clinical role of pteridine therapy in tetrahydrobiopterin deficiency. J Inherit Metab Dis 1985;8(suppl 1):39-45
77. Rowe PB. Inherited disorders of folate metabolism. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, et al, eds. The Metabolic Basis of Inherited Disease. New York, NY: McGraw-Hill; 1983:498-521
78. Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-1454
79. Fava M. Augmenting antidepressants with folate: a clinical perspective. J Clin Psychiatry 2007;68(suppl 10):4-7